DailyIQ
Last updatedjust now

ALGN·Align Technology, Inc.

$144.44
+0.90 (+0.63%)
After Hours
High
$145.00
Open
$143.54
Market Cap
10.10B
52W High
$200.44
Low
$141.86
P. Close
$144.44
P/E
24.43
52W Low
$127.72
Fwd P/E
11.53
DailyIQ Est.
$204.61
Inst. Ownership
50.0%
Short Interest
5.93%
Days to Cover
4.3
NewEarnings release, scored · filed Jul 29, 2026Guidance mixed · tone -5.2 vs prior release · 114 lines scoredSee the breakdown
Technical Score (1D)
68
BULLISH
News Sentiment
31
BEARISH
The technical picture for Align Technology, Inc. (ALGN) is bullish, scoring 68 out of 100 on the 1D view. Momentum is firm and sentiment, at 31, is diverging from the price action - a combination that historically precedes follow-through moves. Buyers have maintained control above $136.77, and the path of least resistance points toward $148.17. With the bearish MACD posture in place, the setup remains constructive and worth monitoring for continuation. The gap between the 1D chart and the sentiment read is the kind of thing that shows up in hindsight as either the setup that shook out weak hands before running, or the one that should have been faded. Until $148.17 clears with real volume, sizing should reflect that ambiguity rather than the technical score in isolation - $136.77 is the level where that ambiguity gets resolved one way or the other.
LOW TARGET
$155 +6.9%
2 analysts
MEAN TARGET
$199 +37.4%
13 analysts
HIGH TARGET
$235 +62.1%
11 analysts
PRICE RANGE
$155.00 - $235.00
SB / B / H / S / SS
7/9/8/1/1
DAILYIQ EST.
$204.61 (+41.1%)
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NMS
Country
United States
Symbol
ALGN
Description
Align Technology is a global medical device company specializing in digital dentistry solutions. Its core business revolves around the design, manufacture, and marketing of the Invisalign system, a leading brand of clear aligners used to straighten teeth for both adults and teenagers. Align also offers Vivera retainers, designed to maintain the results achieved with Invisalign treatment, and iTero intraoral scanners, which provide digital impressions for various dental procedures. These scanners are integral to the company's value proposition, enabling precise treatment planning and digital workflows for orthodontists and dentists. Operating internationally, Align Technology competes in the dental and orthodontic markets with a focus on innovative technology and digital solutions.
Bought (1Y)
0 shares
$0
Sold (1Y)
0 shares
$0
Blackford Quentin S.-
Award/Grant1,376 shares2026-08-27
MORROW GEORGE J-
Option Exercise1,745 shares2026-05-20
MORROW GEORGE J-
Option Exercise1,745 shares2026-05-20
Conroy Kevin T-
Award/Grant1,836 shares2026-05-20
Conroy Kevin T-
Option Exercise1,745 shares2026-05-20
76/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
67.2%
Net Margin
10.2%
Revenue CAGR
16.4%
Current Ratio
1.36x
Return on Equity
10.1%
Earnings Summary
Align Technology is a global medical device company that specializes in digital dentistry solutions, primarily through its Invisalign clear aligner system, Vivera retainers, and iTero intraoral scanners, positioning it within the medical instruments and supplies sector. In the most recent two quarters, EPS rose from $2.13 in Q1 2025 to $2.49 in Q2 2025, while revenue increased from $979.3 million to $1.012 billion, indicating a modest acceleration in earnings and top‑line growth; however, EPS in Q3 2025 ($2.61) and Q4 2025 ($3.29) continued to beat estimates, with the company consistently outperforming analyst forecasts in 3 of the last 4 quarters. Historically, Align has shown a steady YoY revenue growth trajectory, with revenue growth decelerating slightly in recent periods, yet EPS growth has remained robust, often exceeding expectations even when revenue growth slows, suggesting efficient cost management. Recent news highlights a cautious valuation shift, with Stifel and Evercore ISI downgrading the stock and lowering price targets, reflecting concerns over the company’s limited compound annual growth rates in revenue and earnings; this sentiment may temper investor enthusiasm despite solid earnings performance.

EPS

EstBeatMiss
$2.18$2.49$2.81$3.12$3.43Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.78 - -
Q2'26$2.66$2.64-0.9%
Q1'26$2.33$2.58+11.0%
Q4'25$3.03$3.29+8.5%
Q3'25$2.41$2.61+8.4%
Q2'25$2.57$2.49-3.3%

Revenue

EstBeatMiss
$984M$1.0B$1.0B$1.1B$1.1BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.0B - -
Q2'26$1.1B$1.1B-1.6%
Q1'26$1.0B$1.0B-0.2%
Q4'25$1.1B$1.0B-0.6%
Q3'25 - $996M -
Q2'25 - $1.0B -

Market Data

ALGN Stock Snapshot

BULLISH68/100
$145.00+$0.56 (0.4%)
Market cap
10.10B
P/E ratio
24.4
Day range
$141.86 – $145.00
News sentiment
31/100 · Bearish
Analyst target
$199.21 (+37.4%)
Consensus
Buy · 26 analysts
52-week range+13.5% off low · -27.7% from high
$127.72$200.44
Price $145.00 DailyIQ Est. $204.61

ALGN is trading with the trend behind it, which is what pushes the technical read bullish. Sector peers are worth watching - large caps in Healthcare tend to move together on rotation.

Behaviour On Record

What ALGN's own history says about today's numbers

Realized volatility (21d)
28.1% 26th pct
Below its peak
-80.2%
vs 200-day average
-14.9%
Up days (1y)
50%

Align Technology, Inc. is currently running 28.1% annualised volatility over the last 21 sessions. Measured against ALGN's own 13 years of daily returns rather than a market-wide average, that is the 26th percentile — on the quiet side for this stock, against a typical reading of 36.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

ALGN is trading -80.2% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -42.5%, and the deepest was -72.9% in 2022. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -14.9% from its 200-day moving average. Against every other day in its history, that gap ranks at the 22nd percentile — a narrower gap than it typically runs. Over the past year ALGN closed higher on 50% of sessions, and it is currently 3 sessions into a rising streak.

On October specifically: over 14 years of records, ALGN finished the month higher 7 of 14 times, with a median return of +2.2% and an average of +3.1%. Its strongest month historically has been November at +5.2% on average, its weakest September at -2.3%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: ALGN has opened more than 2% away from the prior close in 194 of 3,266 sessions (5.9% of the time), with the largest gaps running +10.3% and -11.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, ALGN moved an average of 3.0% in the session after earnings, closing higher 1 of those 3 times, with a median move of -2.2% and a largest of -4.0%.

All figures computed from 3,267 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against ALGN's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of ALGN's sector?

Align Technology, Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).

Sector rank
#2 of 12
Sector state
Leading
Sector rotation score
82

Options Market

What is the options market pricing for ALGN?

CallsPuts

For Align Technology, Inc.'s nearest expiry (2026-10-16, 2 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.66), with at-the-money implied volatility around 72.2%. The options market is pricing roughly a ±4.6% move by that expiry — a range of about $141.10–$154.61.

Put/call ratio (2026-10-16)
0.66
ATM implied volatility
72.2%
Total open interest
3,618
Expected move by 2026-10-16
±4.6% ($141.10–$154.61)

Analyst Rating Changes

Are analysts turning bullish or bearish on ALGN?

Stifel most recently reiterated its rating on Align Technology, Inc. to Buy on Oct 9, 2026 with a price target of $175 (from $210). Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.

Latest action
Stifel — Buy
90-day upgrades
0
90-day downgrades
1
Net rating momentum
-1
DateFirmActionRatingPrice target
Oct 9, 2026StifelMaintainedBuy$210 → $175
Oct 5, 2026Evercore ISI GroupDowngradeOutperform → In-Line$220 → $155
Jul 23, 2026UBSMaintainedNeutral$186 → $189
Jul 9, 2026BMO CapitalInitiatedOutperform$209
Apr 30, 2026Evercore ISI GroupMaintainedOutperform$200 → $220
Apr 30, 2026MizuhoMaintainedOutperform$215 → $220
Apr 24, 2026Morgan StanleyMaintainedEqual-Weight$169 → $188
Apr 21, 2026Piper SandlerMaintainedOverweight$220 → $235
Apr 15, 2026CitigroupInitiatedBuy$240
Mar 17, 2026BarclaysUpgradeEqual-Weight → Overweight$200
Feb 26, 2026BarclaysMaintainedEqual-Weight$170 → $200
Feb 9, 2026HSBCUpgradeHold → Buy$150 → $200

Earnings Release, Scored

What did Align Technology, Inc.'s latest earnings release say?

Filed Jul 29, 2026 · SEC Form 8-K, Exhibit 99

Guidance mixed
Tone55.5/ 100-5.2 vs prior release
Hedging words2.63per 100 words+0.34 vs prior release
Tone, last 2 releasesScale 50–70

Most important lines

  1. 1

    We expect Q3’26 worldwide GAAP Gross Margin to be 67.5% to 68.5%, down sequentially approximately by 3 to 4 points, due to the incurrence of one-time charges expected to be approximately $20 to $30 million primarily for accelerated depreciation and restructuring and other charges in Q3'26.

    New this quarterNegative tone
  2. 2

    We now expect 2026 Systems & Services revenue growth to be down 6% to 8% year-over-year as we anticipate a continued mix shift towards lower-priced scanners and more flexible acquisition models in 2H’26.

    New this quarterNegative tone
  3. 3

    We expect 2026 non-GAAP Gross Margin to be up approximately 100 basis points over 2025 non-GAAP Gross Margin.

    New this quarter

Peers & ETF holders

ALGN peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

31/100
Strong NegativeNeutralStrong Positive
BEARISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Stifel reduced its price target for Align Technology (ALGN) to $175 from $210, reflecting a more cautious outlook. The downgrade comes despite the company’s average overweight rating and a mean target of $199.54 from other analysts. The move signals a reassessment of ALGN’s valuation, potentially impacting investor expectations. The adjustment is part of broader market coverage by MT Newswires and FactSet polling. No immediate operational changes were reported.
What did this article say?
Stifel analyst Jonathan Block kept a Buy recommendation for Align Technology (ALGN) but reduced the target price from $210 to $175. The downgrade reflects concerns about the company’s valuation relative to peers and potential earnings pressure. The firm cited weaker margin expectations and a crowded competitive landscape as key factors behind the price cut. The decision signals a modest negative outlook for the stock while preserving a bullish stance.
What did this article say?
Align Technology’s stock has declined 13.6% over the past six months, lagging behind the S&P 500’s 17.5% gain. Analysts cited a sluggish 3.6% compound annual revenue growth over five years and barely rising EPS as key concerns. The company’s performance has prompted caution among investors, who are weighing whether to include ALGN in their portfolios. These factors suggest a negative outlook for the stock, though the impact is not yet materialized.
What did this article say?
The Benzinga article highlighted three health care stocks—Align Technology (ALGN), Dianthus Therapeutics, and Ocular Therapeutix—as oversold based on RSI readings near or below 30. It suggested that these stocks could present value opportunities for investors seeking potential upside. No specific catalysts or earnings guidance were mentioned, and the piece did not indicate any imminent corporate events. The focus remained on technical indicators rather than fundamental developments. Consequently, the article implied a mild, non-material headwind for the sector without concrete upside drivers.
What did this article say?
Align Technology (ALGN) shares fell roughly 1.9% on Monday after Evercore ISI downgraded the stock to in‑line from outperform and reduced its price target to $155 from $220. The downgrade reflected a reassessment of the company’s valuation and growth prospects. Trading volume exceeded 1.2 million shares, well above the daily average of about 891,000, indicating heightened investor activity around the news. The move signals a modest negative sentiment for ALGN, as analysts now view the company’s upside potential as more limited.
What did this article say?
Evercore ISI downgraded Align Technology (ALGN) from Outperform to In‑Line and lowered its price target from $220 to $155. The move follows a review of the company’s recent financials and outlook. The downgrade signals a more cautious view of ALGN’s near‑term growth prospects. Investors reacted with a modest pre‑market decline in the stock. The rating change reflects analysts’ concerns about margin pressure and competitive dynamics in the clear‑aligner market.
What did this article say?
Evercore ISI downgraded Align Technology (ALGN) from Outperform to In‑Line, prompting a 1.7% decline in pre‑market trading on October 5. The downgrade precedes ALGN’s third‑quarter 2026 earnings release scheduled for October 28. Despite record Clear Aligner revenue of $870.9 million in Q2, Systems and Services revenue fell 10.8% due to a shift toward lower‑priced scanners and leasing models. Management maintained a third‑quarter revenue outlook of $1.0‑$1.02 billion and full‑year growth of 3‑4%, while expanding its share‑repurchase program to $400‑$500 million.
What did this article say?
Evercore ISI reduced its recommendation for Align Technology (ALGN) from outperform to in‑line, signaling a more cautious view of the company’s near‑term prospects. The downgrade reflects concerns about the firm’s valuation relative to peers and the potential slowdown in its flagship product demand. The rating change does not alter the average overweight stance or the mean price target of $207.23. The move may influence investor sentiment but is not expected to cause a significant market shift.
What did this article say?
An analyst at HubSpot announced a downgrade of Align Technology, reducing its rating and price target. The decision followed broader market concerns over the company's growth prospects. The downgrade reflects a cautious view on Align’s future earnings potential. The move may influence investor sentiment and trading activity for the stock.

Technical Analysis

Real-time indicators across multiple timeframes

68
BULLISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $5.82B combined position · 15 adding, 10 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▼ Sell8,179,77911.54%$1.28B2026-01-29
BlackRock, Inc.▲ Buy4,419,3666.23%$745.37M2026-08-07
FMR LLC (Fidelity)▲ Buy4,060,0325.73%$684.77M2026-08-13
Capital World Investors▼ Sell3,422,3854.83%$577.22M2026-08-12
Goldman Sachs Group Inc▲ Buy3,372,7604.76%$568.85M2026-08-14
Geode Capital Management, LLC▲ Buy2,245,3153.17%$378.15M2026-08-12
Invesco Ltd.▲ Buy1,413,5671.99%$238.41M2026-08-14
Ruane, Cunniff & Goldfarb L.P.▼ Sell1,171,4551.65%$197.58M2026-08-14
Morgan Stanley▲ Buy1,013,8421.43%$170.99M2026-08-13
Norges Bank▼ Sell904,6231.28%$152.57M2026-08-12
AQR Capital Management LLC▲ Buy899,7311.27%$151.16M2026-08-14
JPMorgan Chase & Co▲ Buy773,1821.09%$134.65M2026-08-12
Northern Trust Corp▼ Sell562,2410.79%$94.83M2026-08-13
Bank of America Corp▲ Buy551,9120.78%$93.09M2026-08-14
Bares Capital Management, Inc.▲ Buy609,7220.86%$76.35M2025-11-14
Citadel Advisors LLC▼ Sell299,0820.42%$50.44M2026-09-02
Wells Fargo & Company▼ Sell280,1450.40%$47.25M2026-08-14
AllianceBernstein L.P.▼ Sell210,1810.30%$36.03M2026-08-14
D. E. Shaw & Co., Inc.▲ Buy211,1420.30%$35.61M2026-08-14
Gotham Asset Management, LLC▲ Buy185,9540.26%$31.36M2026-08-14
Citigroup Inc▲ Buy142,6040.20%$24.05M2026-08-03
Artisan Partners Limited Partnership▼ Sell139,3330.20%$23.50M2026-08-13
Bridgewater Associates, LP▲ Buy82,4000.12%$13.90M2026-08-14
Susquehanna International Group, LLP▼ Sell65,9250.09%$11.12M2026-08-14
Prudential Financial Inc▲ Buy47,1740.07%$7.96M2026-08-12
Q2 2026 flow:3.99M sh bought ($672.13M)1.40M sh sold ($235.82M)net +2.59M sh (+$436.31M)
Congressional Trading Activity
9 disclosed trades · ~$72.0K est. traded value · 4 buys, 5 sells
MemberChamberStateTypeAmountTradedFiled
Lisa McClainHouseMI09▼ Sell$1K - $15K2025-09-112025-10-22
Lisa McClainHouseMI09▲ Buy$1K - $15K2025-08-042025-09-12
Rob BresnahanHousePA08▼ Sell$1K - $15K2025-04-082025-05-08
Gilbert CisnerosHouseCA31▼ Sell$1K - $15K2025-02-262025-03-06
Rob BresnahanHousePA08▲ Buy$1K - $15K2025-02-252025-03-27
Dan SullivanSenateAK▼ Sell$1K - $15K2023-08-222023-09-22
Dan SullivanSenateAK▲ Buy$1K - $15K2023-01-102023-02-13
Tommy TubervilleSenateAL▼ Sell$1K - $15K2022-10-052022-11-10
Tommy TubervilleSenateAL▲ Buy$1K - $15K2021-03-292021-07-23